Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | 138 000 | déclaré | 29 mai 2025 | tx 11+2 564 667 |
| WIRELESS HOLDINGS INC | 64 682 | déclaré | 07 mai 2010 | tx 30+1 503 935−57 922 |
| Sucampo Pharmaceuticals, Inc. | 45 764 | déclaré | 16 déc. 2014 | tx 39+234 048−168 240 |
| CYTRX CORP | 5 000 | déclaré | 15 janv. 2024 | tx 1+5 000 |
| OSIRIS THERAPEUTICS, INC. |
| 0 |
| déclaré |
| 23 nov. 2007 |
| tx 6+125 000−35 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 29 mai 2025 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 138 000 | 0.00 USD | deriv |
| 05 déc. 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 350 000 | 0.00 USD | deriv |
| 25 mars 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 60 000 | 0.00 USD | deriv |
| 15 janv. 2024 | GRANT_AWARD | CYTRX CORP | 5 000 | 0.00 USD | deriv |
| 23 mai 2023 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 420 000 | 0.00 USD | |
| 23 mai 2023 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 300 000 | 0.00 USD | deriv |
| 20 sept. 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 75 000 | 0.42 USD | |
| 19 sept. 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 25 000 | 0.43 USD | |
| 18 août 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 1 000 000 | 0.00 USD | |
| 23 févr. 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 6 667 | 0.00 USD | deriv |
| 07 déc. 2021 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 130 000 | 0.00 USD | deriv |
| 02 nov. 2021 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 60 000 | 0.00 USD | deriv |
| 16 déc. 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 42 900 | 12.91 USD | |
| 16 déc. 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 42 900 | 4.07 USD | |
| 15 déc. 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 7 100 | 12.89 USD | |
| 15 déc. 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 7 100 | 4.07 USD | |
| 16 déc. 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 42 900 | 0.00 USD | deriv |
| 15 déc. 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 7 100 | 0.00 USD | deriv |
| 11 sept. 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 25 000 | 0.00 USD | deriv |
| 11 sept. 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 22 027 | 0.00 USD | deriv |
| 31 mars 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 220 | 6.79 USD | |
| 30 juin 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 267 | 6.56 USD | |
| 27 févr. 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 2 500 | 4.07 USD | |
| 27 févr. 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 2 390 | 9.00 USD | |
| 27 févr. 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 110 | 9.06 USD |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 18 déc. 2009.